A protein might belong to multiple biological networks simultaneously
En los laboratorios de Málaga, un equipo de investigadores ha reconfigurado la manera en que la ciencia observa el interior de la célula viva, desarrollando una metodología capaz de cartografiar las complejas redes de interacción proteica con una fidelidad sin precedentes. Publicado en Briefings in Bioinformatics, el trabajo surge de la colaboración entre cuatro instituciones y se aplica a las RASopatías, enfermedades genéticas raras que durante décadas han resistido la comprensión plena. En el horizonte más amplio de la medicina, este avance representa algo que la ciencia persigue con paciencia: no una cura inmediata, sino la claridad necesaria para que las curas sean posibles.
- Las enfermedades raras como los síndromes de Noonan y Costello afectan a pacientes cuyos mecanismos biológicos permanecían ocultos incluso tras décadas de investigación genética.
- El obstáculo central era metodológico: los algoritmos tradicionales forzaban a cada proteína a pertenecer a una sola red, ignorando que en la biología real una proteína opera en múltiples sistemas a la vez.
- El equipo malagueño mejoró el algoritmo HLC para permitir que las proteínas ocupen simultáneamente varias comunidades funcionales, generando un mapa celular radicalmente más preciso.
- Aplicada a las RASopatías —causadas por mutaciones en la vía RAS/MAPK—, la nueva metodología identificó genes candidatos que los análisis convencionales no habían detectado.
- El resultado no es un tratamiento, sino algo igualmente valioso: una herramienta que despeja la visión y acelera el camino hacia diagnósticos y terapias dirigidas para enfermedades que antes eran casi invisibles.
Un equipo de investigadores malagueños ha dado un paso significativo en la comprensión de cómo funcionan las proteínas dentro de las células humanas. El trabajo, publicado en la revista Briefings in Bioinformatics, es fruto de la colaboración entre la Universidad de Málaga, el Instituto de Investigación Biomédica de Málaga, el Centro de Investigación Biomédica en Red de Enfermedades Raras y el Instituto Nacional de Bioinformática.
Durante décadas, los científicos han utilizado algoritmos que asignan cada proteína a una única comunidad funcional, como si se tratara de organizar personas en grupos cerrados. Pero la biología celular no responde a esa lógica: una sola proteína puede participar en múltiples redes al mismo tiempo. Para capturar esa realidad, el equipo perfeccionó el algoritmo de Clustering Jerárquico de Enlaces —HLC, por sus siglas en inglés—, permitiendo que las proteínas pertenezcan simultáneamente a varios espacios funcionales. El resultado es un mapa celular mucho más fiel a lo que ocurre realmente dentro del organismo.
Para validar su enfoque, los investigadores lo aplicaron a las RASopatías, un conjunto de enfermedades genéticas raras provocadas por mutaciones en la vía de señalización RAS/MAPK, que incluye síndromes como el de Noonan y el de Costello. A pesar de los avances en secuenciación genética, los mecanismos que conectan estas enfermedades seguían siendo poco claros. Con la nueva metodología, el equipo identificó genes candidatos que los análisis convencionales habían pasado por alto.
Más allá de las RASopatías, la herramienta desarrollada en Málaga tiene el potencial de transformar el abordaje de las enfermedades genéticas raras en general. No resuelve el problema de un día para otro, pero elimina uno de sus mayores obstáculos: la incapacidad de ver con claridad lo que sucede en el interior de la célula.
A team of researchers in Málaga has cracked open a fundamental puzzle in human biology: how proteins actually work together inside our cells. The breakthrough, published in the journal Briefings in Bioinformatics, offers a new way to map the hidden architecture of protein interactions—and with it, a clearer path toward diagnosing and treating rare genetic diseases that have long resisted understanding.
The work emerged from a collaboration between four research institutions: the Molecular Bases of Biological Systems group at the University of Málaga, the Málaga Biomedical Research Institute, Spain's Network Research Center for Rare Diseases, and the National Bioinformatics Institute. What they've done is fundamentally rethink how we visualize proteins and their relationships. For decades, scientists have used algorithms that assign each protein to a single community or functional group—a clean, orderly approach that mirrors how we might organize people into clubs or teams. But proteins don't work that way. In the actual biology of a living cell, a single protein participates in multiple networks simultaneously, just as a person in real life might belong to a family, a workplace, a sports league, and a book club all at once.
The researchers improved an existing algorithm called Hierarchical Link Clustering, or HLC, to recognize and map these overlapping protein communities. The innovation is subtle but powerful: instead of forcing each protein into one box, the new methodology allows proteins to occupy multiple functional spaces at the same time. This creates what amounts to a far more accurate map of how proteins organize themselves and collaborate in cellular processes. The tool reveals hidden relationships that traditional methods would have missed entirely, opening new possibilities for understanding how cells actually function in health and disease.
To test their approach, the team applied it to a group of interconnected rare diseases called RASopatías. These conditions are caused by mutations in genes that control a critical cellular pathway known as RAS/MAPK. The diseases present a bewildering range of symptoms and include syndromes like Noonan and Costello. Despite advances in genetic sequencing, the complete mechanisms driving these diseases and the connections between them have remained murky. Using their new protein-mapping methodology, the researchers identified new candidate genes that may be associated with RASopatías—genes that conventional analysis had not flagged.
The significance of this work extends beyond any single disease. By developing a more accurate way to understand how proteins interact and organize themselves, the researchers have created a tool that could accelerate diagnosis and treatment development across the entire landscape of rare genetic disorders. For patients and families living with conditions that are poorly understood and difficult to treat, this represents a genuine shift in what becomes possible. The methodology doesn't solve the problem overnight, but it removes a major obstacle: the inability to see clearly what was actually happening inside the cell.
Notable Quotes
In real biology, just as in social life, a single element can be part of different groups— Research team explanation of the methodology's core insight
The Hearth Conversation Another angle on the story
Why does it matter that proteins belong to multiple groups instead of just one?
Because that's how they actually work. A protein might help regulate cell growth in one context and manage inflammation in another. If you only see it as belonging to one group, you miss half the story of what it does and how it fails when something goes wrong.
So the old way was like looking at a person and only knowing their job, never their family or hobbies?
Exactly. And when that person gets sick, you'd have no idea why because you never understood the full picture of their life. Same with proteins.
How does this help with rare diseases specifically?
Rare diseases are rare partly because they're caused by mutations in genes that control complex, interconnected systems. When you can finally see how all those proteins actually talk to each other, you can spot which ones are misbehaving and why. That's when you can start to fix it.
The study mentions RASopatías—what makes those diseases so hard to understand?
They all stem from the same pathway, but they cause wildly different symptoms. That shouldn't happen if the pathway was simple. The new mapping revealed that the proteins involved are doing more than anyone realized—they're part of multiple networks. Once you see that, the diversity of symptoms starts to make sense.
What happens next? Is this ready to help patients?
Not immediately. This is a tool that lets researchers ask better questions. But yes, it accelerates everything downstream—diagnosis, understanding why treatments work or don't, designing new therapies. It's foundational work that makes the next steps possible.